HEZKUE
Live / Registered — Registered (as of 31 Mar 2026)
What this means for you
Registered since 31 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97236725
- Registration number
- 8196427
- Mark type
- Stylized text
- Filed
- 25 Jan 2022
- Published for opposition
- 13 Jun 2023
- Registered
- 31 Mar 2026
- Attorney of record
- Anthony E. Bennett
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical compounds, namely, pharmaceutical preparations for the treatment of erectile dysfunction and for the treatment of hypertension; pharmaceutical preparations, namely, sildenafil for the treatment of erectile dysfunction and for the treatment of hypertension; pharmaceutical preparations in the nature of an oral spray formulation of sildenafil for the treatment of erectile dysfunction and for the treatment of hypertension; a drug delivery device prefilled with pharmaceutical products for the treatment of erectile dysfunction and for the treatment of hypertension
Owner
- Aspargo Laboratories, Inc., Englewood Cliffs, NJ, US
- Aspargo Laboratories, Inc., Englewood Cliffs, NJ, US
- Aspargo Laboratories, Inc., Englewood Cliffs, NJ, US
Prosecution history
- 31 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 31 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 09 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Sept 2025 — USE AMENDMENT FILED
- 07 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 08 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Aug 2025 — SOU EXTENSION 4 GRANTED
- 07 Aug 2025 — SOU EXTENSION 4 FILED
- 07 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Feb 2025 — SOU EXTENSION 3 GRANTED
- 07 Feb 2025 — SOU EXTENSION 3 FILED